Functional Expression of Fused Enzymes Between Human Cytochrome P4501A1 and Human NADPH-Cytochrome P450 Oxidoreductase inSaccharomyces cerevisiae
- 1 April 1995
- journal article
- Published by Mary Ann Liebert Inc in DNA and Cell Biology
- Vol. 14 (4) , 273-283
- https://doi.org/10.1089/dna.1995.14.273
Abstract
The activity of human cytochrome P450 enzymes heterologously expressed in Saccaromyces cerevisiae cells is limited by the yeast endogenous cytochrome P450 oxidoreductase (yOR). To overcome these limitations, we constructed hybrids between human P4501A1 (CYP1A1) and human P450 oxidoreductase (hOR) by combining the cDNA encoding hOR with the CYP1A1 cDNA. In addition, in one construct, the amino terminus of hOR was replaced by the membrane anchor domain of a yeast protein. Anchoring of the fusion constructs in internal membranes either by the amino terminus of hOR or by the yeast peptide resulted in functional hybrid proteins, which were present in similar amounts as the authentic CYP1A1 in microsomal fractions of recombinant cells. Saccharomyces cerevisiae cells transformed with the expression plasmids produced the respective proteins in the expected molecular sizes reactive with both anti-CYP1A immunoglobulin (Ig) and anti-oxidoreductase Ig. Saccharomyces cerevisiae yOR-mutant (cpr1-) and wild-type (CPR1+) cells containing the fused enzymes exhibited CYP1A1-specific 7-ethoxyresorufin-O-deethylase activities. Reduced CO-difference spectra of microsomal fractions containing the fused enzymes indicated a proper incorporation of protoheme into the CYP1A1 domains. These results show that the chimeric proteins represent catalytically self-sufficient monooxygenase systems. The hOR domains of the hybrid proteins were also functional as cytochrome c reductases and able to activate the yeast P450 enzyme lanosterol-14 alpha-demethylase, indicating correct insertion of the chimeric proteins in internal membranes.Keywords
This publication has 32 references indexed in Scilit:
- High promutagen activating capacity of yeast microsomes containing human cytochrome P-450 1A and human NADPH-cytochrome P-450 reductaseCarcinogenesis: Integrative Cancer Research, 1994
- Role of human cytochrome P‐450s in risk assessment and susceptibility to environmentally based diseaseJournal of Toxicology and Environmental Health, 1993
- Recombinant yeast in drug metabolismToxicology, 1993
- Expression of human cytochrome P450 enzymes in yeast and bacteria and relevance to studies on catalytic specificityToxicology, 1993
- Enhanced in vivo monooxygenase activities of mammalian P450s in engineered yeast cells producing high levels of NADPH-P450 reductase and human cytochrome b5Gene, 1993
- Functional co-expression of human oxidoreductase and cytochrome P450 1A1 in Saccharomyces cerevisiae results in increased erod activityBiochemical and Biophysical Research Communications, 1992
- Production of cytochrome P450 reductase yeast-rat hybrid proteins in Saccharomyces cerevisiaeGene, 1992
- The Human Hepatic Cytochromes P450 Involved in Drug MetabolismCritical Reviews in Toxicology, 1992
- Constitutive and inducible expression of human cytochrome P450IA1 in yeast Saccharomyces cerevisiae: An alternative enzyme source for in vitro studiesBiochemical and Biophysical Research Communications, 1990
- Expression of Rat NADPH-Cytochrome P-450 Reductase cDNA inSaccharomyces cerevisiaeDNA, 1986